Although type 2 diabetes is often regarded as a disease of ageing, cases of type 2 diabetes in children and adolescents have ...

Xencor remains a 'Strong Buy' in my view despite the stock's 60% performance decline. Click here to find out why XNCR stock ...

Long-term results from the ALLEGRO clinical trial program of ritlecitinib show that complete scalp regrowth occurs in a good ...

The FDA has expanded the indication of Incyte’s Opzelura (ruxolitinib) cream to include children aged two to 11 years with ...

Roche Holding AG's acquisition of 89bio, Inc. to expand cardiometabolic offerings and drive growth beyond GLP-1. Click for ...

As an example of functional integration, products with filling scales and thermochromic imprints that can monitor temperature ...

Weight-loss medications reduced body weight in children and teens, but the sample size was too small to make conclusions ...

This biotech's recent stroke drug trial results appeared to disappoint investors, but there was plenty of positive nuance in ...

A study reveals that even small daily portions of processed meats or soft drinks increase the risk of diabetes, cancer, and ...

ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...